articleTop 1% cited
Pathology of Drug-Eluting Stents in Humans
Journal of the American College of Cardiology · 2006 · Vol. 48(1) · pp. 193–202
Michael Joner(CVPath Institute)Aloke V. Finn(Massachusetts General Hospital)Andrew Farb(United States Food and Drug Administration)Erik K. Mont(Miami Dade College)Frank D. Kolodgie(CVPath Institute)Elena Ladich(CVPath Institute)Robert Kutys(CVPath Institute)Kristi Skorija(CVPath Institute)Herman K. Gold(Massachusetts General Hospital)Renu Virmani✉(CVPath Institute)
Coronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease ManagementMedicineRestenosisThrombosisCardiologyStentDrug-eluting stentInternal medicineThrombusZotarolimusSurgery
MeSH terms
AdultAgedCoronary ThrombosisCoronary VesselsFemaleHumansMaleMetalsMiddle AgedMyocardial InfarctionWound HealingStentsDeath, Sudden, CardiacPaclitaxelSirolimus
Funding
- U.S. Food and Drug Administration
Citations
2,716
FWCI
178.22
field-weighted impact
References
40
Percentile
100%
vs. same field & year
Citations per year
Cited by
Vascular Responses to Drug Eluting Stents
Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 890 citations
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
The Annals of Thoracic Surgery · 2007 · 974 citations
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Circulation · 2011 · 3,292 citations
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Journal of the American College of Cardiology · 2011 · 2,157 citations
Clinical End Points in Coronary Stent Trials
Circulation · 2007 · 5,387 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.